Teisha Rowland

Teisha Rowland

Company: Umoja Biopharma

Job title: Principal Scientist


Engineering iPSCs with Synthetic Receptors to Drive Differentiation Compatible with Scale-Up 12:00 pm

By genetically engineering iPSCs to express a synthetic cytokine receptor, iPSCs can more efficiently be differentiated into functional, persistent immune cell types Differentiation can be performed in suspension, making it compatible with efficient scale-up production This overall approach may be used in a manufacturing setting to drive high purity immune cell productionRead more

day: Day Two

Panel: Designing the ‘Perfect’ Scale-Up Strategy 2:45 pm

Reflecting on the needs and requirements for future scale-up to prepare an ecosystem fit for purpose Reviewing technology innovations to revolutionize iPSC manufacture in the pursuit for commercializationRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.